Banning WuXi is more complicated than it might sound
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Category: Pharmaceuticals
STAT+: Boehringer Ingelheim to cap asthma inhaler out-of-pocket costs at $35
Facing criticism over its pricing, Boehringer Ingelheim plans to cap out-of-pocket costs at $35 a…
Biden to propose expanding Medicare drug price negotiation in State of the Union
WASHINGTON — President Biden wants to more than double the size of Medicare’s new drug…
STAT+: Republicans consider a new attack on Biden ‘march-in’ plan for lower drug prices
WASHINGTON — Republicans in Congress might try to use a technical maneuver to block the…
Where’s Lilly’s Alzheimer’s approval?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Novo Nordisk’s diabetes drug Ozempic cuts risk of kidney disease progression, trial shows
LONDON — Novo Nordisk’s diabetes medication Ozempic cut the risk of patients developing advanced kidney…
First over-the-counter birth control pill in U.S. begins shipping to stores
WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this…
STAT+: ‘It’s a nightmare’: One of the most common children’s asthma meds is no longer available, leaving families scrambling
A commonly prescribed medication for children’s asthma is disappearing from pharmacists’ shelves, forcing parents and…
STAT+: White House touts incremental step in Medicare drug price negotiation: counteroffers
WASHINGTON — The White House on Monday ballyhooed a routine step in Medicare’s new program…
STAT+: Massachusetts lawmakers consider $1 billion proposal to bolster region’s life science leadership
Next stop: Beacon Hill. Governor Maura Healey’s long-awaited plan to double down on state funding…
Serum Institute of India wants government HPV contract
Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
CVS and Walgreens plan to start dispensing abortion pill mifepristone soon
The drugstore chains CVS Health and Walgreens plan to start dispensing an abortion pill in a few…
STAT+: Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies
A growing number of alternative pharmacies — such as those run by Costco, Amazon, and…
Despite good data, Ironwood’s shares plummet
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Here are the cancer drugs Pfizer thinks could reignite investors’ interest
Pfizer spent more than four hours Thursday laying out its oncology program to investors. But…
House looks to weaken Medicare negotiation
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
The next act for a biotech rainmaker
Want to stay on top of the science and politics driving biotech today? Sign up to…
Q&A: A biotech VC leader shares her next big bets
Kristina Burow has a well-trained eye. That’s true of her work at ARCH Venture Partners,…
STAT+: Pfizer is about to make a big push in cancer. Will investors listen?
Pfizer has a big problem. The drug giant hopes that new drugs to treat cancer…
STAT+: White House to hold a listening session on reforming pharmacy benefit managers
In a bid to combat prescription drug costs, the White House will hold a listening…
Beam is trading like it’s 2021
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about Congress punts PBM reform, another obesity drug and more
Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are…
GSK pill works in uncomplicated gonorrhea
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Protocols originally intended to be extra conservative are now heralded as evidence of mifepristone’s risk
Decisions made by the Food and Drug Administration more than 20 years ago have come…
The FDA isn’t afraid to yank a disappointing drug
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Obesity treatment from Boehringer Ingelheim, Zealand Pharma succeeds in study in liver condition MASH
LONDON — A drug in development as a weight loss treatment succeeded in a Phase…
STAT+: Oregon suspends a portion of its drug transparency law found to be unconstitutional
In a victory for the pharmaceutical industry, Oregon officials have suspended a portion of a…
STAT+: Amgen’s rheumatoid arthritis drug Enbrel targeted for first-in-the-nation price limit in Colorado
WASHINGTON — Colorado is pioneering a new way for states to crack down on prescription…
STAT+: UnitedHealth cyberattack cripples pharmacies’ and hospitals’ ability to process insurance claims
Hospitals, pharmacies, and other health care providers are getting stuck in an insurance processing logjam…
.jpg)
What do CEOs owe the world?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Stump Pharmalot: An Ask Me Anything with Ed Silverman
In 2023, STAT launched a brand-new home for our subscribers to connect with each other…
Novavax’s money is going in the wrong direction
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Actually Wegovy is good for dialysis companies, dialysis provider says
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: AbbVie CEO Gonzalez to step down after a decade fiercely defending its top seller, Humira
AbbVie announced Tuesday that CEO Richard Gonzalez, who has managed the company’s ascent since it…
Bayer, short on cash, reaches into shareholders’ pockets
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: A lawsuit over a controversial Sanofi drug shortage is unexpectedly revived
A U.S. appeals court revived a controversial lawsuit brought by nearly two dozen people who…
Opinion: The complicated connections between weight loss drugs and mental health
Mental illness can cause or worsen obesity, and obesity can cause or worsen mental illness….
Alnylam thickened the plot
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: FDA cracks down on websites that claim to sell chemicals in obesity drugs Wegovy, Zepbound
The Food and Drug Administration is cracking down on websites that claim to sell the…
STAT+: Hospital claims it was ‘drastically’ overcharged by pharma in a federal drug discount program
For several years, some of the world’s largest pharmaceutical companies that participate in a U.S….
Pharma’s contractors might finally be on the rebound
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Leaked version of EFTA-India free trade deal sparks alarm over access to medicines
A leaked version of a proposed agreement between India and the European Free Trade Association…
Replicate’s srRNA rabies vaccine effective in Phase 1
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Biogen Alzheimer’s drug launch off to slow start
Seven months after US drug regulators fully approved Biogen’s treatment for Alzheimer’s disease, only about…
The need to know biotech news stories today
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Startup BioAge raises $170 million Series D for Zepbound combination therapy
A California biotech developing a combination therapy with the obesity drug Zepbound has raised a…
STAT+: Judge tosses PhRMA lawsuit over Medicare power to negotiate drug prices
WASHINGTON — A federal district judge on Monday granted the Biden administration’s request to dismiss…
Psychedelic investment continues to ramp up
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Major generic maker Aurobindo cuts production at a key plant amid concerns over shortages
Aurobindo, which is one of the largest generic drug makers, has halted some production at…
Does Moderna’s RSV vaccine lose efficacy faster than others?
Want to stay on top of the science and politics driving biotech today? Sign up to get…